Edwards Lifesciences Corporation (FRA:EWL)
65.97
+0.51 (0.78%)
Last updated: Aug 14, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Transcatheter Aortic Valve Replacement | 4.11B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Transcatheter Aortic Valve Replacement Growth | 6.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Surgical Structural Heart | 981.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Surgical Structural Heart Growth | 2.78% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Critical Care | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Critical Care Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Transcatheter Mitral and Tricuspid Therapies | 352.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Transcatheter Mitral and Tricuspid Therapies Growth | 68.71% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
United States | 3.21B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | 9.04% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | 1.32B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | 10.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Japan | 339.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Japan Growth | 0.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of World | 572.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of World Growth | 11.01% |
Log In |
Log In |
Log In |
Log In | Upgrade
|